UA101996C2 - Соединение, которое содержит интерлейкин-1 и пептид - Google Patents

Соединение, которое содержит интерлейкин-1 и пептид

Info

Publication number
UA101996C2
UA101996C2 UAA201107126A UAA201107126A UA101996C2 UA 101996 C2 UA101996 C2 UA 101996C2 UA A201107126 A UAA201107126 A UA A201107126A UA A201107126 A UAA201107126 A UA A201107126A UA 101996 C2 UA101996 C2 UA 101996C2
Authority
UA
Ukraine
Prior art keywords
heading
peptide
normal
composition containing
composition
Prior art date
Application number
UAA201107126A
Other languages
English (en)
Ukrainian (uk)
Inventor
Игорь Анатольевич Помиткин
Игорь Артурович Петропавлов
Original Assignee
Юнайтед Технолоджис Ут Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юнайтед Технолоджис Ут Аг filed Critical Юнайтед Технолоджис Ут Аг
Publication of UA101996C2 publication Critical patent/UA101996C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/07Tetrapeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2006IL-1
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • C07K14/545IL-1
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1002Tetrapeptides with the first amino acid being neutral
    • C07K5/1016Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение относится к дерматологической или косметической композиции, которая характеризуется тем, что содержит (а) интерлейкин-1 альфа; (б) пептид формулы (I) Tyr-D-Ala-Gly-Phe-Leu-Asp; (в) дерматологически приемлемый разбавитель или наполнитель, причем содержание интерлейкина-1 альфа составляет от 10до 10вес. %, содержание пептида - от 10до 10вес. %. Композиция дополнительно содержит буфер в концентрации, эффективной для поддержания рН композиции между 4.0 и 7.5.
UAA201107126A 2008-11-07 2008-11-07 Соединение, которое содержит интерлейкин-1 и пептид UA101996C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2008/065152 WO2010051852A1 (en) 2008-11-07 2008-11-07 Compositions containing interleukin-1 and peptides

Publications (1)

Publication Number Publication Date
UA101996C2 true UA101996C2 (ru) 2013-05-27

Family

ID=40600193

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201107126A UA101996C2 (ru) 2008-11-07 2008-11-07 Соединение, которое содержит интерлейкин-1 и пептид

Country Status (8)

Country Link
US (1) US8298523B2 (ru)
EP (1) EP2364160B1 (ru)
JP (1) JP5537556B2 (ru)
KR (2) KR101504893B1 (ru)
CN (1) CN102209552A (ru)
EA (1) EA021186B1 (ru)
UA (1) UA101996C2 (ru)
WO (1) WO2010051852A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0924416B1 (pt) * 2009-03-17 2017-06-06 United Tech Ut Ag composição tópica e métodos cosméticos de melhoria de aparência e da firmeza e elasticidade, de condicionamento, de redução da severidade da celulite, de estrias e de rugas, de redução e/ou prevenção de cicatrizes, de aumento da produção de colágeno e elastina da pele e uso de composição.
CA2963570A1 (en) * 2013-10-28 2015-05-07 Atp Institute Pty Ltd Pain relief formulation and method of treatment
RU2664702C1 (ru) * 2017-03-10 2018-08-21 Сергей Георгиевич Морозов Способ профилактики несостоятельности межкишечного анастомоза при операциях на брюшной полости с помощью пептида
EP3641725A1 (en) 2017-06-23 2020-04-29 The Procter and Gamble Company Composition and method for improving the appearance of skin
EP3817717A1 (en) 2018-07-03 2021-05-12 The Procter & Gamble Company Method of treating a skin condition
RU2718912C1 (ru) * 2019-12-24 2020-04-15 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт общей патологии и физиологии" (ФГБНУ "НИИОПП") Способ лечения и профилактики инфаркта миокарда с патологией легких
JP2023528616A (ja) 2020-06-01 2023-07-05 ザ プロクター アンド ギャンブル カンパニー ビタミンb3化合物の皮膚への浸透を改善する方法
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816436A (en) * 1986-10-29 1989-03-28 Immunex Corporation Anti-arthritic use of interleukin-1 proteins
DE3883252T2 (de) * 1987-12-18 1993-11-25 Immunex Corp Örtliche wundheilmittel, die interleukin-1-proteine enthalten.
US5202118A (en) * 1987-12-18 1993-04-13 Immunex Corporation Method for promoting wound healing using IL-1
EP0644203A1 (en) * 1988-07-29 1995-03-22 Otsuka Pharmaceutical Co., Ltd. IL-1alpha derivatives and medicament for treating thrombocytopenia
ZA902663B (en) 1989-04-07 1991-12-24 Syntex Inc Interleukin-1 formulation
US5035887A (en) * 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
JP2587711B2 (ja) 1990-05-09 1997-03-05 大塚製薬 株式会社 抗腫瘍剤
RU2017488C1 (ru) * 1990-12-26 1994-08-15 Курский Государственный Медицинский Институт Средство для лечения псориаза
JP2818834B2 (ja) * 1991-08-12 1998-10-30 大塚製薬株式会社 IL−1α安定化医薬製剤
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
RU2230549C2 (ru) * 2001-12-06 2004-06-20 Дальневосточный государственный медицинский университет Способ лечения аллергических дерматозов
JP4018033B2 (ja) 2003-06-18 2007-12-05 バンドー化学株式会社 ブレード素材とその製造方法および製造装置
RU2286140C1 (ru) * 2005-02-21 2006-10-27 Светлана Николаевна Киппер Крем для чувствительной кожи
ES2259928B1 (es) 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
EA019154B1 (ru) * 2008-04-24 2014-01-30 Юнайтед Текнолоджис Ут Аг Гексапептиды и композиции на их основе

Also Published As

Publication number Publication date
EA021186B1 (ru) 2015-04-30
US20110189126A1 (en) 2011-08-04
US8298523B2 (en) 2012-10-30
KR20110092288A (ko) 2011-08-17
WO2010051852A1 (en) 2010-05-14
CN102209552A (zh) 2011-10-05
EP2364160B1 (en) 2013-04-10
JP5537556B2 (ja) 2014-07-02
KR20140066209A (ko) 2014-05-30
EP2364160A1 (en) 2011-09-14
JP2012508195A (ja) 2012-04-05
KR101504893B1 (ko) 2015-03-23
EA201100459A1 (ru) 2011-10-31

Similar Documents

Publication Publication Date Title
UA101996C2 (ru) Соединение, которое содержит интерлейкин-1 и пептид
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
UA98658C2 (ru) Циклические депсипептиды
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
MX2009006055A (es) Formas cristalinas del acido (3s)-3-[n-(n'-(2-terc-butilfenil)oxam il)alaninil]amino-5-(2',3',5',6'-tetrafluorofenoxi)-4-oxopentanoi co.
DE60321775D1 (de) Carbaminsäurederivate enthaltend eine piperazin verknüpfung als hdac-inhibitoren
TW200718424A (en) Novel compounds of amino sulfonyl derivatives
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
PE20090727A1 (es) DERIVADOS DE AMIDA COMO INHIBIDORES DE NaV1.7
MY139522A (en) New alkyl-pyridines as 11-beta inhibitors for diabetes
DE502005008631D1 (de) Dermatologischen zubereitungen
EA200601279A1 (ru) Пиперидинилкарбонилпирролидины и их применение в качестве агонистов меланокортина
NO20082498L (no) Diarylurea for behandling av pulmonar hypertensjon
MA32776B1 (fr) Inhibiteurs de l'akt et de la p70 s6 kinase
EA201200968A1 (ru) Применение транс-кломифена для предотвращения или лечения диабета 2 типа у мужчин
EA201170289A1 (ru) Фармацевтические композиции и способы их получения при низкой концентрации примесей
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
EA200702375A1 (ru) Производные мочевины, способы их получения и применения
ATE462703T1 (de) Bicyclononen-derivate als renin-inhibitoren
SG158091A1 (en) Imidazoazepinone compounds
BR112012017188A2 (pt) composto agonista de mgluz, sua composição farmacêutica e seu uso
DE502006008630D1 (de) Kosmetische zusammensetzung zur stimulierung der synthese der proteine der basalmembran
ATE473752T1 (de) Verwendung von verbindungen zur induktion der synthese von sirt-proteinen bei der oder für die herstellung eines kosmetikums oder einer pharmazeutischen zusammensetzung
IN2011KN05169A (ru)
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами